NeoCore Technology Co

NeoCore Technology Co Inventory

The Inventory of NeoCore Technology Co (4131.TWO) as of Nov 11, 2026 is 3.70 M TWD. In the previous year, Inventory was 66.38 M TWD — a change of -94.42% (lower).

Inventory

3.70 MTWD

YoY

-94.42%

Last updated:

Inventory of NeoCore Technology Co is 2024 3.70 M TWD. Inventory of NeoCore Technology Co was 2023 66.38 M TWD. It decreases by -94.42% lower compared to the previous year.

The NeoCore Technology Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2017
4.44 M TWD
Jan 1, 2018
56.30 M TWD
Jan 1, 2019
76.51 M TWD
Jan 1, 2020
110.08 M TWD
Jan 1, 2021
92.63 M TWD
Jan 1, 2022
60.58 M TWD
Jan 1, 2023
66.38 M TWD
Jan 1, 2024
3.70 M TWD
The NeoCore Technology Co Inventory history
YEARInventoryYoY
3.70 MTWD-94.42%
66.38 MTWD+9.57%
60.58 MTWD-34.59%
92.63 MTWD-15.85%
110.08 MTWD+43.87%
76.51 MTWD+35.91%
56.30 MTWD+1,167.12%
4.44 MTWD-11.86%
5.04 MTWD-16.10%
6.01 MTWD+1.08%
5.94 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NeoCore Technology Co Stock analysis

What does NeoCore Technology Co do? NeoCore Technology Co Ltd generates revenue through the sale of biochips and related biotechnology products. The company develops and manufactures DNA/RNA sample preparation kits, polymerase chain reaction kits, rapid hybridization equipment, biochips, testing reagents, biological preparations, nucleic acid sequencing detection systems, biotechnology control hardware and software, and biomedical materials. These products are primarily sold within Taiwan and exported to Asian and European markets. The company's domestic sales focus on the Taiwanese market while international exports target Asian and European customers. DR. Chip Biotechnology, Inc. operates as the parent company for NeoCore Technology Co Ltd, managing the research, development, manufacturing, and sales of biochips. The business model relies on direct sales of its comprehensive product portfolio to domestic and international clients in the biotechnology sector. The company's product range serves both laboratory and commercial applications within the biotechnology industry. NeoCore Technology Co Ltd's revenue streams include the sale of biochips, DNA/RNA sample preparation kits, polymerase chain reaction kits, and related components. The company's export focus on Asia and Europe drives international sales, while domestic sales in Taiwan form a significant portion of its business. The company's product offerings cater to the needs of biotechnology laboratories and commercial entities requiring advanced biotech solutions. NeoCore Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NeoCore Technology Co stock

Inventory of NeoCore Technology Co is 3.70 M TWD in 2024.

Inventory of NeoCore Technology Co changed from 66.38 M TWD to 3.70 M TWD, representing a -94.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory NeoCore Technology Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's NeoCore Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — NeoCore Technology Co

All Key Metrics — NeoCore Technology Co